Inhibition of L-type Cav1.2 Ca2+ -channels by 2,(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002) and 2-[1-(3-Dimethylaminopropyl)-5-methoxyindol-3-yl]-3-(1H-indol-3-yl) maleimide (Gö6983).


Welling A, Hofmann F & Wegener JW

Mol. Pharmacol. 2005, 67, 541 – 544